Home
Contact
Sitemap
Search
ABOUT PHOTOCURE
NEWS
News archive
PRODUCTS
OUR TECHNOLOGY
R&D
INVESTORS
BUSINESS DEVELOPMENT
PRESS/MEDIA
PHOTOCURE US
NEWS
Subscribe to our news.
News
2012.02.02
Photocure’s partner Ipsen announces 4Q 11 Hexvix® sales in Germany and Italy
2012.01.13
Photocure announces completion of Visonac® study enrolment
2012.01.09
Photocure ASA - Photocure strengthens the Management Team
2012.01.03
Photocure ASA - Cevira Study completes study enrolment on time
2011.12.30
Photocure ASA: Photocure Announces Transfer of Marketing Authorisation for Cysview in the USA
2011.12.06
DnB Nor Nordic Health Care Conference 2011
2011.12.05
Photocure - repurchase program of own shares
2011.12.05
Photocure presenting at Nordic health care conference 2011
2011.11.29
Photocure appoints interim Chief Financial Officer
2011.11.28
Photocure nominates market maker on oslo stock exchange
2011.11.18
Photocure announces resignment of Chief Financial Officer
2011.11.07
3rd Quarter Report 2011
2011.10.24
Invitation to a presentation of the 3rd quarter report 2011
2011.10.14
Photocure announces the achievement of the first transition milestone of Eur 2.0 million for Hexvix®
2011.09.27
Photocure announces new commercial strategy for Hexvix®, the innovative product for improved detection of bladder cancer
2011.08.22
From NBC - Cysview and cancer detection
2011.08.18
Presentation of the 2nd Quarter results 2011
2011.07.18
Photocure initiates enrollment into phase II trial of Visonac® for treatment of moderate to severe acne
2011.06.22
Photocure Launches Allumera® A New, Dynamic Cosmetic For Achieving Timeless Skin
2011.06.22
Photocure initiates enrollment into phase II trial of Cevira® for cervical HPV infection
2011.05.30
Photocure Announces First Commercial Sale of Allumera® in the US
2011.05.12
Hexvix®/Cysview(TM) demonstrates long term benefit
2011.05.12
Photocure Strengthens the Management Team
2011.05.12
Photocure Announces Key Changes to the Board of Directors
2011.04.28
1st Quarter result presentation